Peptide Council launches to establish compounding standards

The Pharmacy Compounding Accreditation Council, operating as the Peptide Council, launched on July 27, 2026, to establish the first peptide-specific compounding standards. For medical aesthetics clinics relying on compounded peptides for anti-aging or wellness protocols, this independent nonprofit initiative aims to standardize quality across the entire supply chain, from active pharmaceutical ingredient sourcing to patient dispensing. The launch occurred days after the FDA Pharmacy Compounding Advisory Committee recommended six of seven peptide substances for inclusion on the 503A Bulks List, with emideltide being the only substance rejected. Backed by the Accreditation Commission for Health Care, which currently accredits more than 900 pharmacies, the new council already has documented interest from more than 20 compounding pharmacies. Official program inspections are targeted to begin later in 2026. For practices integrating custom peptide therapies, this accreditation will soon serve as a critical safety benchmark. Clinicians should proactively ask their current compounding partners if they intend to seek this council's credential to protect their practices from the regulatory and clinical risks of unverified suppliers.

Source: The American Journal of Managed Care, https://www.ajmc.com/view/accreditation-body-targets-sourcing-testing-and-marketing-practices-as-the-fda-advisory-panel-recommends-expanding-access-to-compounded-peptides